Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study

Fig. 2

Effectiveness results – OS and PFS. a Overall survival stratified by rash. The dashed red curve depicts patients with any rash. The continuous blue curve shows patients without rash. b Progression-free survival stratified by rash. The dashed red curve depicts patients with any rash. The continuous blue curve shows patients without rash. c Progression-free survival stratified by the grade of cutaneous reactions. The continuous blue curve depicts patients without rash. The dashed green curve shows patients with rash grade 1. The dotted red curve displays patients with grade ≥ 2 skin reactions. d Progression-free survival stratified by age. The continuous blue curve shows patients aged ≤65 years. The dotted red curve shows patients aged ≥ 65 years

Back to article page